Technical failure rates for biometry between swept-source and older-generation optical coherence methods: a review and meta-analysis.

Cataract Intraocular lens calculation Low-coherence optical reflectometry Optical biometry Partial coherence interferometry Swept-source optical coherence tomography

Journal

BMC ophthalmology
ISSN: 1471-2415
Titre abrégé: BMC Ophthalmol
Pays: England
ID NLM: 100967802

Informations de publication

Date de publication:
26 Apr 2023
Historique:
received: 29 09 2022
accepted: 18 04 2023
medline: 28 4 2023
pubmed: 27 4 2023
entrez: 26 4 2023
Statut: epublish

Résumé

Precise ocular measurements are fundamental for achieving excellent target refraction following both cataract surgery and refractive lens exchange. Biometry devices with swept-source optical coherence tomography (SS-OCT) employ longer wavelengths (1055-1300 nm) in order to have better penetration through opaque lenses than those with partial coherence interferometry (PCI) or low-coherence optical reflectometry (LCOR) methods. However, to date a pooled analysis showing the technical failure rate (TFR) between the methods has not been published. The aim of this study was to compare the TFR in SS-OCT and in PCI/LCOR biometry. PubMed and Scopus were used to search the medical literature as of Feb 1, 2022. The following keywords were used in various combinations: optical biometry, partial coherence interferometry, low-coherence optical reflectometry, swept-source optical coherence tomography. Only clinical studies referring to patients undergoing routine cataract surgery, and employing at least two (PCI or LCOR vs. SS-OCT) optical methods for optical biometry in the same cohort of patients were included. Fourteen studies were included in the final analysis, which presented results of 2,459 eyes of at least 1,853 patients. The overall TFR of all included studies was 5.47% (95% confidence interval [CI]: 3.66-8.08%; overall I A meta-analysis of the TFR of different biometry methods highlighted that SS-OCT biometry resulted in significantly decreased TFR compared to PCI/LCOR devices.

Identifiants

pubmed: 37101115
doi: 10.1186/s12886-023-02926-0
pii: 10.1186/s12886-023-02926-0
pmc: PMC10131302
doi:

Types de publication

Meta-Analysis Review Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

182

Informations de copyright

© 2023. The Author(s).

Références

Ophthalmic Physiol Opt. 2013 Jan;33(1):7-14
pubmed: 23252852
Clin Exp Optom. 2019 Sep;102(5):533-534
pubmed: 30806991
Eye (Lond). 2017 Mar;31(3):437-442
pubmed: 27834962
Diagnostics (Basel). 2022 Jan 19;12(2):
pubmed: 35204334
J Clin Med. 2019 May 20;8(5):
pubmed: 31137510
J Biomed Opt. 2007 Jul-Aug;12(4):041211
pubmed: 17867800
PLoS One. 2019 Oct 11;14(10):e0223114
pubmed: 31603903
J Cataract Refract Surg. 2019 Aug;45(8):1124-1129
pubmed: 31174987
Ann Transl Med. 2020 Nov;8(22):1553
pubmed: 33313298
Int Ophthalmol. 2019 May;39(5):1115-1122
pubmed: 29700651
Am J Ophthalmol. 2023 Feb;246:236-241
pubmed: 36252676
J Cataract Refract Surg. 2021 Jul 1;47(7):859-864
pubmed: 33577278
Ann Transl Med. 2020 Nov;8(22):1541
pubmed: 33313286
Am J Ophthalmol. 2017 Jun;178:58-64
pubmed: 28263734
Diagnostics (Basel). 2022 Feb 26;12(3):
pubmed: 35328151
JAMA Ophthalmol. 2019 Jan 1;137(1):118-119
pubmed: 30347027
J Cataract Refract Surg. 2002 Sep;28(9):1546-50
pubmed: 12231308
Eur J Ophthalmol. 2019 Sep;29(5):547-554
pubmed: 30295063
Transl Vis Sci Technol. 2020 Aug 07;9(9):14
pubmed: 32879770
J Cataract Refract Surg. 2021 Jun 1;47(6):802-814
pubmed: 33315731
J Refract Surg. 2017 Oct 1;33(10):690-695
pubmed: 28991337
J Cataract Refract Surg. 2016 Jan;42(1):62-7
pubmed: 26948779
Clin Exp Optom. 2010 Nov;93(6):379-89
pubmed: 20735786
Sci Rep. 2021 Jan 13;11(1):983
pubmed: 33441703
BMC Ophthalmol. 2018 Oct 19;18(1):269
pubmed: 30340561
Clin Ophthalmol. 2020 Dec 02;14:4209-4220
pubmed: 33293790
Br J Ophthalmol. 2017 Apr;101(4):493-498
pubmed: 27503393
J Ophthalmol. 2017;2017:1516395
pubmed: 29375908
J Cataract Refract Surg. 2016 Jan;42(1):50-61
pubmed: 26948778
Curr Pharm Des. 2018;24(41):4896-4902
pubmed: 30727876
J Cataract Refract Surg. 2019 Nov;45(11):1619-1624
pubmed: 31706516
Ophthalmic Res. 2019;62(1):11-23
pubmed: 30889604
Ophthalmology. 2018 Feb;125(2):169-178
pubmed: 28951074
J Cataract Refract Surg. 2015 Dec;41(12):2598-604
pubmed: 26796439
J Cataract Refract Surg. 2020 Jan;46(1):27-33
pubmed: 32050229
Diagnostics (Basel). 2021 Aug 13;11(8):
pubmed: 34441401
J Cataract Refract Surg. 2016 Apr;42(4):577-81
pubmed: 27113881
PLoS One. 2015 Jun 10;10(6):e0128929
pubmed: 26061554
Eur J Ophthalmol. 2015 May-Jun;25(3):192-7
pubmed: 25449642
Am J Ophthalmol. 2017 Jan;173:64-69
pubmed: 27664702
Clin Ophthalmol. 2022 Mar 05;16:661-668
pubmed: 35282169
Opt Express. 2005 May 2;13(9):3252-8
pubmed: 19495226
BMC Ophthalmol. 2019 Jan 24;19(1):30
pubmed: 30678658
Br J Ophthalmol. 2016 Sep;100(9):1201-5
pubmed: 26674777
J Refract Surg. 2020 Jul 1;36(7):459-465
pubmed: 32644168
Asia Pac J Ophthalmol (Phila). 2020 May-Jun;9(3):186-193
pubmed: 32501896
J Refract Surg. 2019 Feb 1;35(2):115-120
pubmed: 30742226
J Cataract Refract Surg. 2022 Jan 1;48(1):26-31
pubmed: 34034291
PLoS One. 2018 Apr 24;13(4):e0196401
pubmed: 29689110
Ophthalmol Ther. 2018 Jun;7(1):119-124
pubmed: 29498015
J Cataract Refract Surg. 2015 Oct;41(10):2224-32
pubmed: 26703299

Auteurs

Piotr Kanclerz (P)

Department of Ophthalmology, Hygeia Clinic, ul. Jaśkowa Dolina 57, Gdańsk, 80-286, Poland. p.kanclerz@gumed.edu.pl.
Helsinki Retina Research Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland. p.kanclerz@gumed.edu.pl.

Idan Hecht (I)

Helsinki Retina Research Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Department of Ophthalmology, Shamir Medical Center, Tel Aviv, Israel.

Raimo Tuuminen (R)

Helsinki Retina Research Group, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
Eye Centre, Kymenlaakso Central Hospital, Kotka, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH